General Information of Drug (ID: DMQ6POC)

Drug Name
Pyridoxamine-5'-Phosphate Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
1053
ChEBI ID
CHEBI:18335
CAS Number
CAS 529-96-4
TTD Drug ID
DMQ6POC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cycloserine DMT1I52 Bacterial infection 1A00-1C4Z Approved [1]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [1]
Lysine Nz-Carboxylic Acid DMW1YK3 Discovery agent N.A. Investigative [1]
Propionate DM0O8N6 Discovery agent N.A. Investigative [2]
Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate DM7AW0X Discovery agent N.A. Investigative [1]
N-(5'-Phosphopyridoxyl)-D-Alanine DM3FCAI Discovery agent N.A. Investigative [1]
Pyridoxyl-Alanine-5-Phosphate DMUVCWY Discovery agent N.A. Investigative [1]
Propanoic Acid DM9TN2W Discovery agent N.A. Investigative [1]
3-fluorovinylglycine DMECBLA Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetate Ion DMD08RH Discovery agent N.A. Investigative [1]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Alpha-ketoisovalerate DMBZTS5 Discovery agent N.A. Investigative [1]
N-[O-Phosphono-Pyridoxyl]-Isoleucine DM6EICU Discovery agent N.A. Investigative [1]
N'-(phenylsulfonyl)benzofuran-2-carbohydrazide DMJO3B1 Discovery agent N.A. Investigative [4]
N'-(phenylsulfonyl)quinoline-6-carbohydrazide DMQETUY Discovery agent N.A. Investigative [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Branched-chain-amino-acid transaminase 2 (BCAT2) TTF9OQ6 BCAT2_HUMAN Inhibitor [1]
Mycobacterium Biosynthetic alanine racemase (MycB alr) TT6TMZU ALR_MYCSM Inhibitor [1]
Staphylococcus D-amino acid aminotransferase (Stap-coc dat) TTN6GE9 DAAA_STAHA Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers. 2003 Oct;70(2):186-200.
3 Mechanism-based inactivation of alanine racemase by 3-halovinylglycines. J Biol Chem. 1991 Nov 15;266(32):21657-65.
4 The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett. 2006 May 1;16(9):2337-40.